Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2012

Biotron completes clinical stage of HIV clinical trial

28 April 201314 December 2012 by Karen Mobbs

Biotron completes clinical stage of HIV clinical trial

Categories 2012

Results of Annual General Meeting

28 April 201328 November 2012 by Karen Mobbs

Results of Annual General Meeting

Categories 2012

Presentation to Annual General Meeting

28 February 201428 November 2012 by Justine Bednorz

Presentation to Annual General Meeting

Categories 2012, ASX Announcements

Commencement of three-month toxicology studies for BIT225

28 April 201327 November 2012 by Karen Mobbs

Commencement of three-month toxicology studies for BIT225

Categories 2012

Key Phase 2 HIV/HCV trial commenced

28 April 20139 November 2012 by Karen Mobbs

Key Phase 2 HIV/HCV trial commenced

Categories 2012

Presentation to investors

28 February 201426 October 2012 by Justine Bednorz

Presentation to investors

Categories 2012, ASX Announcements

Annual Report for year ended 30 June 2012 and Notice of Annual General Meeting

28 April 201325 October 2012 by Karen Mobbs

Annual Report for year ended 30 June 2012 and Notice of Annual General Meeting

Categories 2012

Quarterly Report 30 September 2012

28 April 201323 October 2012 by Karen Mobbs

Quarterly Report 30 September 2012

Categories 2012, Quarterly Reports

Biotron Limited to report new clinical data from BIT225 Hepatitis C Phase 2a trial in a late-breaking presentation at the AASLD 2012 annual conference

28 April 201316 October 2012 by Karen Mobbs

Biotron Limited to report new clinical data from BIT225 Hepatitis C Phase 2a trial in a late-breaking presentation at the AASLD 2012 annual conference

Categories 2012

October edition of BITNews

28 April 201311 October 2012 by Karen Mobbs

October 2012 edition of BITNews

Categories 2012, Newsletters
Older posts
Page1 Page2 Page3 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 6 June 2025        Legal Notices and Privacy
Cleantalk Pixel